These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9861552)

  • 21. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Golubchik P; Kodesh A; Weizman A
    Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-handicapping prior to academic-oriented tasks in children with attention deficit/hyperactivity disorder (ADHD): medication effects and comparisons with controls.
    Waschbusch DA; Craig R; Pelham WE; King S
    J Abnorm Child Psychol; 2007 Apr; 35(2):275-86. PubMed ID: 17195950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An examination of the effects of stimulant medication on response inhibition: a comparison between children with and without attention deficit hyperactivity disorder.
    Brackenridge R; McKenzie K; Murray GC; Quigley A
    Res Dev Disabil; 2011; 32(6):2797-804. PubMed ID: 21700419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
    Konstenius M; Jayaram-Lindström N; Beck O; Franck J
    Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
    Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
    J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive Improvement of Attention and Inhibition in the Late Afternoon in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Osmotic-Release Oral System Methylphenidate.
    Slama H; Fery P; Verheulpen D; Vanzeveren N; Van Bogaert P
    J Child Neurol; 2015 Jul; 30(8):1000-9. PubMed ID: 25296928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
    Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphenidate.
    Nolan EE; Gadow KD
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):597-604. PubMed ID: 9136493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication.
    Bedard AC; Ickowicz A; Logan GD; Hogg-Johnson S; Schachar R; Tannock R
    J Abnorm Child Psychol; 2003 Jun; 31(3):315-27. PubMed ID: 12774864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate.
    Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Camfferman G; Buitelaar JK; Koelega HS
    Psychophysiology; 2000 May; 37(3):334-46. PubMed ID: 10860411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
    Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of methylphenidate on impulsive responding in children with attention-deficit hyperactivity disorder.
    Malone MA; Swanson JM
    J Child Neurol; 1993 Apr; 8(2):157-63. PubMed ID: 8505479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.
    Heishman SJ; Henningfield JE
    Psychopharmacology (Berl); 1991; 103(4):436-42. PubMed ID: 2062984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.